We are live on ! Find out more
BLC

Brown, Lisle/Cummings Portfolio holdings

AUM $400M
1-Year Est. Return 18.79%
This Fund
S&P 500
This Quarter Est. Return
+0.35%
1 Year Est. Return
+18.79%
3 Year Est. Return
+61.76%
5 Year Est. Return
10 Year Est. Return
AUM
$335M
AUM Growth
+$5.97M
Cap. Flow
+$10.1M
Cap. Flow %
3%
Top 10 Hldgs %
27.92%
Holding
666
New
47
Increased
170
Reduced
94
Closed
28

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.02M
2
WRB icon
W.R. Berkley
WRB
+$1.01M
3
AMZN icon
Amazon
AMZN
+$842K
4
GD icon
General Dynamics
GD
+$368K
5
NTR icon
Nutrien
NTR
+$344K

Top Sells

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$501K
2
CVS icon
CVS Health
CVS
+$368K
3
BMY icon
Bristol-Myers Squibb
BMY
+$359K
4
PLTR icon
Palantir
PLTR
+$244K
5
FISV
Fiserv Inc
FISV
+$204K

Sector Composition

Rank Sector Weight
1 Technology 17.74%
2 Healthcare 14.93%
3 Financials 13.98%
4 Industrials 10.27%
5 Communication Services 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSC icon
151
Norfolk Southern
NSC
$75.3B
$446K 0.13%
1,902
+125
+7% +$31.8K
ZTS icon
152
Zoetis
ZTS
$32.6B
$446K 0.13%
2,735
-65
-2% -$11.6K
ORCL icon
153
Oracle
ORCL
$393B
$443K 0.13%
2,660
+250
+10% +$44.4K
BOND icon
154
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.43B
$428K 0.13%
4,734
-37
-0.8% -$3.41K
BA icon
155
Boeing
BA
$179B
$426K 0.13%
2,406
+160
+7% +$25.1K
TSM icon
156
TSMC
TSM
$2.09T
$421K 0.13%
2,130
-100
-4% -$19.4K
IWD icon
157
iShares Russell 1000 Value ETF
IWD
$82.4B
$419K 0.13%
2,262
CE icon
158
Celanese
CE
$4.84B
$415K 0.12%
6,000
INTC icon
159
Intel
INTC
$455B
$407K 0.12%
20,311
-835
-4% -$18.8K
MFC icon
160
Manulife Financial
MFC
$73.8B
$405K 0.12%
13,199
+549
+4% +$17K
OMC icon
161
Omnicom Group
OMC
$21.9B
$396K 0.12%
4,600
AZEK
162
DELISTED
The AZEK Co
AZEK
$387K 0.12%
8,150
-1,075
-12% -$51.4K
SPHD icon
163
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.38B
$385K 0.11%
7,970
+620
+8% +$31K
PNRG icon
164
PrimeEnergy Resources
PNRG
$294M
$375K 0.11%
1,708
-225
-12% -$40.7K
IDV icon
165
iShares International Select Dividend ETF
IDV
$8.45B
$368K 0.11%
13,433
+2,064
+18% +$59.1K
EXPD icon
166
Expeditors International
EXPD
$22B
$360K 0.11%
3,250
BNY
167
Bank of New York Mellon
BNY
$105B
$358K 0.11%
4,666
SO icon
168
Southern Company
SO
$108B
$355K 0.11%
4,313
+656
+18% +$57.6K
WM icon
169
Waste Management
WM
$90.2B
$353K 0.11%
1,750
GE icon
170
GE Aerospace
GE
$379B
$348K 0.1%
2,086
+550
+36% +$98.1K
LOW icon
171
Lowe's Companies
LOW
$117B
$346K 0.1%
1,401
CF icon
172
CF Industries
CF
$18.7B
$343K 0.1%
4,016
-250
-6% -$21.6K
DVN icon
173
Devon Energy
DVN
$51.4B
$341K 0.1%
10,420
+7,775
+294% +$293K
MRVL icon
174
Marvell Technology
MRVL
$171B
$337K 0.1%
3,050
+650
+27% +$60.3K
CLX icon
175
Clorox
CLX
$11.9B
$331K 0.1%
2,038

Similar funds

Brown, Lisle/Cummings's Q4 2024 Portfolio in Review

As of Q4 2024, Brown, Lisle/Cummings held 666 positions worth $335M, up 1.8% from $329M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Brown, Lisle/Cummings deployed $10.1M of net new capital in Q4 2024, opening 47 new positions and adding to 170 existing holdings. Its largest new stake was W.R. Berkley: 16,780 shares worth $982K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was T. Rowe Price, an estimated $501K trimmed.

  • Brown, Lisle/Cummings's largest Q4 2024 buy was W.R. Berkley: 16,780 shares worth $982K.
  • Brown, Lisle/Cummings added most to Eli Lilly in Q4 2024, an estimated $1.02M increase.
  • Brown, Lisle/Cummings's biggest Q4 2024 reduction was T. Rowe Price, cutting an estimated $501K.
  • Brown, Lisle/Cummings fully exited TransUnion in Q4 2024, selling an estimated $20.9K.
  • Brown, Lisle/Cummings's ten largest holdings make up 28% of its $335M portfolio in Q4 2024.
  • Brown, Lisle/Cummings opened 47 new positions and closed 28 in Q4 2024.
  • Brown, Lisle/Cummings's portfolio value rose 1.8% quarter-over-quarter to $335M.

Based on Brown, Lisle/Cummings's 13F filing for Q4 2024, filed 27 Jan 2025.